Speakers

Meet Our Esteemed Speakers

Explore the key opinion leaders and renowned academic experts who bring unparalleled knowledge and thought leadership to our annual events.

Biomarkers Speakers

30 September - 01 October 2024 | Basel, Switzerland

Biomarkers Europe 2024

Amanda Heslegrave
Senior Research Fellow,
University College London
Benjamin Weber
Vice President Translational Research,
Novo Nordisk
Brian Lockhart
Global Head of Companion Diagnostics,
Servier
Cornelia Wilson
Reader and Academic Laboratory Director,
Canterbury Christ Church University
Dirk Kemming
Medical Director Diagnostics Europe,
Daiichi Sankyo Europe
Ed Schuuring
Clinical Scientist in Molecular Pathology,
University Medical Center Groningen
Gunther Jansen
Head of Multimodal Data & Analytics,
Novartis
Joanna Janus
Research Programme Manager (Early Detection and Prevention),
Cancer Research UK
Marine Garrido
Translational leader,
Bayer
Olga Nissan
C EO,
Protica Bio
Philip Beer
Chief Scientific Officer,
Step Pharma
Shashank Saran
Associate Director,
AstraZeneca
Aitana Sogorb-Esteve
Senior Research Fellow,
University College London
Andrew Janowczyk
Assistant Professor,
Emory University
Axel Ducret
expert scientist,
F. Hoffmann-La Roche Ltd
Bernhard Reis
Biomarker Lead,
F. Hoffmann-La Roche Ltd.
Bernhard Reis
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
F. Hoffman-La Roche Ltd.
Christian Ruiz
Senior Lecturer; Chief Scientific Officer,
University of Basel; Moonlight AI
Christophe Le Tourneau
Medical Oncologist,
Institut Curie
Dylan Powell
Lecturer Public Health and Innovation,
Stirling University
Fatima Sanfourche
Senior Director of QA & RA Compliance for Medical Devices and eHealth,
Bayer
Guillaume Desachy
Head Of Biometrics,
AstraZeneca
Jacques Colinge
Professor,
University of Montpellier, France
Jan Christoph Brase
Global Precision Medicine Leader,
Bayer
Jehad Charo
Principal scientist - Biomarker Experimental Medicine Leader,
Hoffmann La Roche Ltd
Jon Krell
Senior Clinical Lecturer and Honorary Consultant in Medical Oncology,
Imperial College London
Jose MG Izarzugaza
Head of Department,
Novo Nordisk
Mario Richter
Director II DMPK-BA Global Biomarker Lead,
AbbVie Deutschland GmbH & Co. KG
Maximilian Breitner
Laboratory Head Bioanalytics,
Sandoz
Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde
Pekka Ruusuvuori
Assistant Professor, PI in Bioimage informatics Institute of Biomedicine,,
Turku University
Rodrigo Toledo
Group Leader,
Vall d'Hebron Institute of Oncology
Thomas Jensen
CEO,
Allarity Therapeutics

28 - 29 October 2024 | San Diego, CA, USA

Biomarkers US 2024

Anand Giddabasa
Head of Global Science and Technology, Comparative Medicine,
Pfizer
Arpita Ray
Principal Scientist,
Genentech - South San Francisco, CA
Heather Cohen
Senior Director,
Bicycle Therapeutics
Jean-Francois Martini
Executive Director, BCAT Group Head,
Pfizer Inc
Kristie Grebe
Senior Director of Clinical and Translational Development Clinical Development Lead for Celiac and MS programs,
Anokion
Kristina McGuire
Senior Director, Precision Medicine,
Regeneron
Kyuho Han
Chief Executive Officer,
MEDiC Life Sciences
Lokesh Agrawal
Dir,
NCI
Robert Getzenberg
Medical Director Diagnostics, Oncology,
Astellas
SATYA SAXENA
Director, Global Proteomics,
Eisai, Inc
William Weber
Associate Scientific Director-Pathology-SME,
Takeda
Yang Li
Principal Scientist,
Ionis Pharmaceuticals
Anmarie Boutrin
Medical Devices Regulatory Scientist – Regulatory CMC & Devices,
UCB
Jadwiga Bienkowska
Senior Director, Computational Biology ORD,
Pfizer Ltd
Katie Newhall
VP Translational,
Cellectis
KC Hart
Senior Scientist,
IGM Biosciences
Minghao Song
Director, Precision Medicine Lead,
AstraZeneca
Simon Filosto
Director, Cell Biology, Translational Medicine,
Kite Pharma
Sripad Ram
Digital Pathology and Image Analysis Lead,
Pfizer Inc

12 - 14 February 2025 | London, UK

Biomarkers 2025

Belinda Nedjai
Associate Professor,
Queen Mary University of London
Debayan Mukherjee
Principal Scientist,
GSK
Dmitri Mikhailov
Director,
Novartis
Donna Finch
Head of Translational and Clinical Science,
Alchemab Therapeutics
Jimmy Bell
Professor,
University of Westminster
Julie Lin
Global Project Head, Rare Disease,
Sanofi